Aktiia SA

Aktiia SA

HQ Country
Switzerland
Filtered by:
Aktiia SA
Company
Topic
Show
 
2024
20 Nov 2024

Wearable Sensors Market 2025-2035: Technologies, Trends, Players, Forecasts

IDTechEx Report: Dr Tess Skyrme, Dr Nadia Tsao and Dr Jack Howley
19 Jan 2024

Digital Health and Artificial Intelligence 2024-2034: Trends, Opportunities, and Outlook

IDTechEx Report: Dr Nadia Tsao and Dr Tess Skyrme
2023
20 Mar 2023

Wearable Technology Forecasts 2023-2033

IDTechEx Report: Dr Tess Skyrme and Sam Dale
2022
2 Sep 2022

Remote Patient Monitoring 2023-2033: Technologies, Markets and Opportunities

IDTechEx Report: Dr Nadia Tsao and Dr Tess Skyrme
14 Jan 2022

Biospectal

Biospectal is a Swiss company developing non-invasive blood pressure monitoring software. IDTechEx interviewed Biospectal CEO and co-founder Eliott Jones on 21 Dec 2021.
2021
26 Jan 2021

CE Mark for Breakthrough 24-7 Blood Pressure Monitoring System

Aktiia today announced the first 24-7, automated blood pressure monitoring system that easily and comfortably gathers data during the day and while sleeping. This groundbreaking medical innovation will now provide people and their physicians comprehensive insights into blood pressure patterns that will better inform the diagnosis and management of hypertension.
2020
13 May 2020

Aktiia Cuffless Blood Pressure Monitor Proven Accurate

Aktiia has developed a wrist-worn optical blood pressure monitor that can automatically take measurements around the clock without requiring a specific arm position.
24 Mar 2020

Aktiia Raises Funding for Cuffless Optical Blood Pressure Monitor

Aktiia, a Swiss-US startup that has developed an optical blood pressure monitor at the wrist, has raised an additional CHF 6 million in funding to bring its product to market.
2019
3 Dec 2019

Aktiia

Aktiia has developed an ambulatory blood pressure monitoring wrist-worn device.
4 Nov 2019

Accuracy of Aktiia's Cuffless Blood Pressure Technology is Revealed

Aktiia, a Swiss-US startup that develops optical blood pressure monitors at the wrist, has concluded the analysis of the data of a clinical trial comparing cuffless optical blood pressure measurements at the wrist against invasive references.